195 related articles for article (PubMed ID: 30774867)
1. The anti-apoptotic proteins NAF-1 and iASPP interact to drive apoptosis in cancer cells.
Iosub-Amir A; Bai F; Sohn YS; Song L; Tamir S; Marjault HB; Mayer G; Karmi O; Jennings PA; Mittler R; Onuchic JN; Friedler A; Nechushtai R
Chem Sci; 2019 Jan; 10(3):665-673. PubMed ID: 30774867
[TBL] [Abstract][Full Text] [Related]
2. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Bergamaschi D; Samuels Y; O'Neil NJ; Trigiante G; Crook T; Hsieh JK; O'Connor DJ; Zhong S; Campargue I; Tomlinson ML; Kuwabara PE; Lu X
Nat Genet; 2003 Feb; 33(2):162-7. PubMed ID: 12524540
[TBL] [Abstract][Full Text] [Related]
3. ASPP and iASPP: Implication in cancer development and progression.
Li Y; Ahmad A; Sarkar FH
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):2-8. PubMed ID: 26518890
[TBL] [Abstract][Full Text] [Related]
4. A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
Qiu S; Cai Y; Gao X; Gu SZ; Liu ZJ
Cancer Lett; 2015 Jan; 356(2 Pt B):910-7. PubMed ID: 25444901
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124-mediated regulation of inhibitory member of apoptosis-stimulating protein of p53 family in experimental stroke.
Liu X; Li F; Zhao S; Luo Y; Kang J; Zhao H; Yan F; Li S; Ji X
Stroke; 2013 Jul; 44(7):1973-80. PubMed ID: 23696548
[TBL] [Abstract][Full Text] [Related]
6. Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.
Qiu S; Liu S; Yu T; Yu J; Wang M; Rao Q; Xing H; Tang K; Mi Y; Wang J
BMC Cancer; 2017 Nov; 17(1):795. PubMed ID: 29179704
[TBL] [Abstract][Full Text] [Related]
7. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins.
Ahn J; Byeon IL; Byeon CH; Gronenborn AM
J Biol Chem; 2009 May; 284(20):13812-13822. PubMed ID: 19246451
[TBL] [Abstract][Full Text] [Related]
8. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury.
Wilson AM; Chiodo VA; Boye SL; Brecha NC; Hauswirth WW; Di Polo A
PLoS One; 2014; 9(4):e94175. PubMed ID: 24714389
[TBL] [Abstract][Full Text] [Related]
10. Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells.
Liu ZJ; Cai Y; Hou L; Gao X; Xin HM; Lu X; Zhong S; Gu SZ; Chen J
Cancer Invest; 2008 Nov; 26(9):878-82. PubMed ID: 18798069
[TBL] [Abstract][Full Text] [Related]
11. A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity.
Kramer D; Schön M; Bayerlová M; Bleckmann A; Schön MP; Zörnig M; Dobbelstein M
Cell Death Dis; 2015 Feb; 6(2):e1634. PubMed ID: 25675294
[TBL] [Abstract][Full Text] [Related]
12. iASPP protects the heart from ischemia injury by inhibiting p53 expression and cardiomyocyte apoptosis.
Yagudin T; Zhao Y; Gao H; Zhang Y; Yang Y; Zhang X; Ma W; Daba TM; Ishmetov V; Kang K; Yang B; Pan Z
Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):102-111. PubMed ID: 33128543
[TBL] [Abstract][Full Text] [Related]
13. siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
Liu H; Wang M; Diao S; Rao Q; Zhang X; Xing H; Wang J
Leuk Res; 2009 Sep; 33(9):1243-8. PubMed ID: 19299014
[TBL] [Abstract][Full Text] [Related]
14. FHL2 interacts with iASPP and impacts the biological functions of leukemia cells.
Lu W; Yu T; Liu S; Li S; Li S; Liu J; Xu Y; Xing H; Tian Z; Tang K; Rao Q; Wang J; Wang M
Oncotarget; 2017 Jun; 8(25):40885-40895. PubMed ID: 28402264
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif.
Llanos S; Royer C; Lu M; Bergamaschi D; Lee WH; Lu X
J Biol Chem; 2011 Dec; 286(50):43039-44. PubMed ID: 21998301
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells.
Zhang B; Xiao HJ; Chen J; Tao X; Cai LH
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):219-24. PubMed ID: 21625267
[TBL] [Abstract][Full Text] [Related]
17. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.
Slee EA; Gillotin S; Bergamaschi D; Royer C; Llanos S; Ali S; Jin B; Trigiante G; Lu X
Oncogene; 2004 Dec; 23(56):9007-16. PubMed ID: 15489900
[TBL] [Abstract][Full Text] [Related]
18. The Fe-S cluster-containing NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer.
Bai F; Morcos F; Sohn YS; Darash-Yahana M; Rezende CO; Lipper CH; Paddock ML; Song L; Luo Y; Holt SH; Tamir S; Theodorakis EA; Jennings PA; Onuchic JN; Mittler R; Nechushtai R
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3698-703. PubMed ID: 25762074
[TBL] [Abstract][Full Text] [Related]
19. CDK9 inhibitors reactivate p53 by downregulating iASPP.
Wu J; Liang Y; Tan Y; Tang Y; Song H; Wang Z; Li Y; Lu M
Cell Signal; 2020 Mar; 67():109508. PubMed ID: 31866490
[TBL] [Abstract][Full Text] [Related]
20. In vitro effect of iASPP on cell growth of oral tongue squamous cell carcinoma.
Chen Y; Yan W; He S; Chen J; Chen D; Zhang Z; Liu Z; Ding X; Wang A
Chin J Cancer Res; 2014 Aug; 26(4):382-90. PubMed ID: 25232209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
